Orange Lifts Guidance After Strong Growth in Africa, Middle East Segment
The French telecommunications company now expects growth in earnings before interest, taxes, depreciation, amortization after leases of more than 3%, up from its previous forecast of around 3%.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Eltek Sets Earnings Release Date and Conference Call to Report Second Quarter 2025 Results on August 14, 2025
PETACH-TIKVA, Israel, Aug. 4, 2025 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today that it will release its financial results for the second quarter of 2025 before the market opens on Thursday, August 14, 2025. Eltek's financial results will be released over the news wires and will be posted on its corporate website at: On Thursday, August 14, 2025, at 9:00 a.m. Eastern Time, Eltek will conduct a conference call to discuss the results. The call will feature remarks by Eli Yaffe, Chief Executive Officer and Ron Freund, Chief Financial Officer. To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call: United States: 1-866-860-9642Israel: 03- 9180691International: +972-3-9180691 At: 9:00 a.m. Eastern Time 6:00 a.m. Pacific Time 16:00 p.m. Israel Time A replay of the call will be available through the Investor Info section on Eltek's corporate website at approximately 24 hours after the conference call is completed and will be archived for 30 days. About Eltek Eltek – "Innovation Across the Board", is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs) and is an Israeli leading company in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high-quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia. Eltek was founded in 1970. The Company's headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiary in North America and by agents and distributors in Europe, India, South Africa and South America. For more information, visit Eltek's web site at Investor Contact Ron FreundChief Financial OfficerInvestor-Contact@ Logo: View original content: SOURCE Eltek Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Tower Semiconductor: Q2 Earnings Snapshot
MIGDAL HAEMEK, Israel (AP) — MIGDAL HAEMEK, Israel (AP) — Tower Semiconductor Ltd. (TSEM) on Monday reported earnings of $46.6 million in its second quarter. The Migdal Haemek, Israel-based company said it had net income of 41 cents per share. Earnings, adjusted for stock option expense, came to 50 cents per share. The chipmaker posted revenue of $372.1 million in the period. For the current quarter ending in September, Tower Semiconductor said it expects revenue in the range of $395 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TSEM at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
MediWound to Report Second Quarter 2025 Financial Results
MediWound to Report Second Quarter 2025 Financial Results Conference call and webcast scheduled for Thursday, August 14 at 8:30 a.m. Eastern Time YAVNE, Israel, August 4, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the second quarter ended June 30, 2025 on Thursday, August 14, 2025. Following the release, MediWound's management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss these financial results and provide corporate updates. Dial-in and call details are as follows: Conference Call & Webcast Details Toll-Free: 1-844-676-8833Israel: 1-80-9212373International: 1-412-634-6869Webcast: Webcast Link To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay on the Investors section of the MediWound website. About MediWound MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company focused on developing and commercializing enzymatic therapies for non-surgical tissue repair. The company's FDA-approved biologic, NexoBrid®, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the U.S., European Union, Japan, and other international markets. MediWound is also advancing EscharEx®, a late-stage investigational therapy for the debridement of chronic wounds. EscharEx has demonstrated clinical advantages over the leading enzymatic debridement product and targets a substantial global market opportunity. For more information visit and follow us on LinkedIn. MediWound Contacts: Hani Luxenburg Daniel FerryChief Financial Officer Managing DirectorMediWound Ltd. LifeSci Advisors, LLCir@ daniel@ Media Contact: Ellie HansonFINN Partners for +1-929-588-2008
